Related Experiment Video
Updated: May 31, 2026
Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
Molecular imaging of epidermal growth factor receptor kinase activity
Amjad P Khan1, Joseph N Contessa, Mukesh K Nyati
1Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Abstract:
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, is commonly altered in different tumor types, leading to abnormally regulated kinase activity and excessive activation of downstream signaling cascades, including cell proliferation, differentiation, and migration. To investigate the EGFR signaling events in real time and in living cells and animals, here we describe a multidomain chimeric reporter whose bioluminescence can be used as a surrogate for EGFR kinase activity. This luciferase-based reporter was developed in squamous cell carcinoma cells (UMSCC1) to generate a cancer therapy model for imaging EGFR. The reporter is designed to act as a phosphorylated substrate of EGFR and reconstitutes luciferase activity when it is not phosphorylated, thereby providing a robust indication of EGFR inhibition. We validated the reporter in vitro and demonstrated that its activity could be differentially modulated by EGFR tyrosine kinase inhibition with erlotonib or receptor activation with epidermal growth factor. Further experiments in vivo demonstrated quantitative and dynamic monitoring of EGFR tyrosine kinase activity in xenograft. Results obtained from these studies provide unique insight into pharmacokinetics and pharmacodynamics of agents that modulate EGFR activity, revealing the usefulness of this reporter in evaluating drug availability and cell targeting in both living cells and mouse models.
Insights
Researchers developed a novel bioluminescent reporter to monitor epidermal growth factor receptor (EGFR) kinase activity in real-time. This tool aids in evaluating cancer therapies targeting EGFR signaling in living cells and animal models.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Epidermal growth factor receptor (EGFR) is a key receptor tyrosine kinase frequently altered in various cancers.
- Dysregulated EGFR signaling drives tumor progression through uncontrolled cell proliferation, differentiation, and migration.
- Real-time monitoring of EGFR activity is crucial for understanding cancer biology and evaluating targeted therapies.
Purpose of the Study:
- To develop and validate a novel bioluminescent reporter system for real-time imaging of EGFR kinase activity.
- To create a cancer therapy model for in vitro and in vivo imaging of EGFR in squamous cell carcinoma.
- To assess the utility of the reporter in evaluating the pharmacokinetics and pharmacodynamics of EGFR-modulating agents.
Main Methods:
- Development of a luciferase-based, multidomain chimeric reporter sensitive to EGFR phosphorylation.
- Validation of the reporter in UMSCC1 squamous cell carcinoma cells.
- In vitro assessment of reporter modulation by EGFR inhibition (erlotinib) and activation (epidermal growth factor).
- In vivo evaluation of the reporter in xenograft models for quantitative and dynamic monitoring of EGFR activity.
Main Results:
- The developed reporter system successfully visualized EGFR kinase activity in real-time.
- Reporter activity was modulated by EGFR tyrosine kinase inhibitors and activators, confirming its specificity.
- In vivo studies demonstrated quantitative and dynamic monitoring of EGFR activity in xenografts.
- The reporter provided insights into drug pharmacokinetics and pharmacodynamics.
Conclusions:
- A novel bioluminescent reporter enables real-time, quantitative monitoring of EGFR kinase activity.
- This reporter system serves as a valuable tool for cancer therapy research, particularly for evaluating EGFR-targeted drugs.
- The reporter facilitates assessment of drug availability and cell targeting in preclinical models.
